NOVAGO

Chemical products, namely, for the regenerative treatment of disorders affecting human beings, including but not limited to, central nervous system, eye, skin and other disorders; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes, namely, biological monoclonal antibodies and formulations for human therapeutic use; biological preparations for use in industry and science; peptides for chemical products and foodstuffs in the nature of biological monoclonal antibodies and formulations for human therapeutic use; polypeptides; antibodies and proteins for scientific use

Pharmaceutical preparations, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; veterinary preparations, namely, for the regenerative treatment of disorders, including, but not limited to, central nervous system, eye, skin and other; preparations for immunotherapeutic purposes, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; products for the removal of tumors, namely preparations for neurodegenerative diseases, namely, but not limited to, traumatic brain injury, spinal cord injury, stroke; immunogens for medical use, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; vaccines, antibodies, epitopes for pharmaceutical use; peptides for pharmaceutical purposes; sanitary preparations for medical use for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; biological preparations for medical use for the treatment of neurological, ophthalmic, skin disorders; biocides; diagnostic products, namely, for the development of new therapeutic agents; towels for hygiene purposes, namely, sanitary towels; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposes, namely, for the regenerative treatment of disorders, including, but not limited to, central nervous system, eye, skin and other disorders

Monitoring of degenerative and traumatic disorders affecting human beings for quality control purposes; Research in the field of regenerative treatment of degenerative or traumatic human disorders research in the field of sanitary care; computer software design, computer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparations, namely, preparations for regenerative treatment of human disorders; software maintenance

Medical services; medical services in the field of immunity; provision of medical information; medical examinations, namely, assessments used for clinical research purposes; dispensing of pharmaceuticals; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care; veterinary assistance in the nature of veterinary services, namely, assessments and procedures that leads to novel pharmaceutical products; beauty salon services; care services for animals, namely, for the regenerative treatment of veterinary trauma disorders; hygienic care; consultancy and provision of information relating to the operation, preparation, administration and dosage of pharmaceutical preparations